CompletedPhase 4NCT03562130

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Olivier GOULET, MD, PhD
Assistance Publique - Hôpitaux de Paris
Intervention
Teduglutide(drug)
Enrollment
25 enrolled
Eligibility
2-18 years · All sexes
Timeline
2018 – 2020

Study locations (1)

Collaborators

Imagine Institute · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03562130 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome →

← Back to all trials